Herpetic Neuralgia Clinical Trial
Official title:
Prevention Effect of Pregabalin on Postherpetic Neuralgia: A Multicenter, Randomized, Double-blind, Controlled Trial
Pregabalin is effective on herpetic neuralgia, but whether can prevention post-herpetic neuralgia still need to confirm.
Pregabalin has been recommended as the first—line drug for post-herpetic neuralgia (PHN)
therapy currently due to its efficacy and safety. However,there was no valuable report at
present on the clinical efficacy of pregabalin for acute and subacute herpetic neuralgia
(SHN), expect for a smaller study which included 29 outpatients who had acute zoster pain
for a period of 7-1 4 days. And it is not clear whether early application of pregabalin can
reduce the incidence of PHN.
Therefore, this study was rational designed to evaluate the efficacy and safety of
pregabalin in the treatment of herpetic neuralgia，and follow—up to the 8 months, evaluation
whether impacting the accidence of PHN.
It is the first time in the international that treating acute herpetic neuralgia (AHN) and
SHN with pregabalin as a large sample size clinical trial. The results of this study will be
great significance for guiding the clinical medication.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05763550 -
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia
|
Phase 2 |